Free Trial

Amplifon (OTCMKTS:AMFPF) Sets New 1-Year Low - What's Next?

Amplifon logo with Medical background
Image from MarketBeat Media, LLC.

Key Points

  • New 52-week low: Amplifon shares fell to $10.50, down about 27% from the prior close of $15.6650, on light volume (310 shares) during the trading session.
  • Mixed fundamentals and weak liquidity: The company has a market cap of $2.32B and a P/E of 18.36, but a debt-to-equity ratio of 1.14 and low liquidity metrics (quick ratio 0.54, current ratio 0.62), with 50‑ and 200‑day moving averages at $15.74 and $16.50 respectively.
  • Business profile: Amplifon is a global leader in hearing care and retail distribution of hearing aids and related services, founded in Milan in 1950 and now operating a multinational store and partner network.
  • Five stocks to consider instead of Amplifon.

Amplifon S.p.A. (OTCMKTS:AMFPF - Get Free Report)'s stock price reached a new 52-week low during trading on Monday . The company traded as low as $10.50 and last traded at $10.50, with a volume of 310 shares trading hands. The stock had previously closed at $15.6650.

Amplifon Trading Down 27.0%

The firm has a market capitalization of $2.32 billion, a price-to-earnings ratio of 18.36 and a beta of 0.46. The company has a debt-to-equity ratio of 1.14, a quick ratio of 0.54 and a current ratio of 0.62. The company has a 50 day moving average price of $15.74 and a two-hundred day moving average price of $16.50.

Amplifon Company Profile

(Get Free Report)

Amplifon is a global leader in hearing care, specializing in the retail and distribution of hearing aids, accessories and related services. The company offers a full suite of solutions including diagnostic hearing assessments, personalized hearing aid fittings, follow-up care, tinnitus management and hearing protection. Through its network of branded stores and partner outlets, Amplifon serves individuals across the full spectrum of hearing needs, from prevention and early detection to long-term aftercare.

Founded in Milan in 1950 by Algernon Charles Holland, Amplifon has grown from a single audiology centre into a multinational organization.

Featured Articles

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Amplifon Right Now?

Before you consider Amplifon, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Amplifon wasn't on the list.

While Amplifon currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

10 Best Stocks to Own in 2026 Cover

Click the link to see MarketBeat's list of ten stocks that are set to soar in 2026, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines